EUVIMEDEUVIMED entdecken
Open Access

Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy

Babatunde Samuel Obadawo, Priscila Cristina Bartolomeu Halicki iD, Kindra L Becker, Jessica C Seeliger iD, Kyle H Rohde iD, Steven J Sucheck iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.4c01054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Babatunde Samuel Obadawo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Toledo, 2801 West Bancroft Street, Toledo, Ohio 43606, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Benzoxazoles, Antitubercular Agents, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Pharmaceutical Research and Manufacturers of America Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisBenzoxazolesAntitubercular AgentsBacterial ProteinsEnzyme InhibitorsStructure-Activity RelationshipMicrobial Sensitivity TestsDrug DiscoveryHumans

Stichwörter der Autor:innen

Mycobacterium tuberculosis (Mtb)Pks13 inhibitorsantitubercular therapybenzoxazole derivativesscaffold hoppingstructure−activity relationships (SAR)

Substanzen

BenzoxazolesAntitubercular AgentsBacterial ProteinsEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Toledo, 2801 West Bancroft Street, Toledo, Ohio 43606, United States.
  • Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32827, United States.
  • Department of Chemistry, Stony Brook University, Stony Brook, New York 11794, United States.
  • Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794, United States.

ORCID-Profile: Priscila Cristina Bartolomeu Halicki, Jessica C Seeliger, Kyle H Rohde, Steven J Sucheck

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Pharmaceutical Research and Manufacturers of America Foundation
  • National Institute of General Medical Sciences

Zitieren

APA

Obadawo, B. S., Bartolomeu Halicki, P. C., Becker, K. L., Seeliger, J. C., Rohde, K. H., & Sucheck, S. J. (2025). Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c01054

Vancouver

Obadawo BS, Bartolomeu Halicki PC, Becker KL, Seeliger JC, Rohde KH, Sucheck SJ. Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c01054

BibTeX
@article{Obadawo2025,
  author = {Obadawo, Babatunde Samuel and Bartolomeu Halicki, Priscila Cristina and Becker, Kindra L and Seeliger, Jessica C and Rohde, Kyle H and Sucheck, Steven J},
  title = {Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.4c01054}
}
Kostenlos starten →